SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049207
Filing Date
2024-04-26
Accepted
2024-04-26 16:30:24
Documents
16
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A stro-20240425.htm   iXBRL DEF 14A 1213869
2 GRAPHIC img142447830_0.jpg GRAPHIC 6391
3 GRAPHIC img142447830_1.jpg GRAPHIC 26413
4 GRAPHIC img142447830_2.jpg GRAPHIC 25010
5 GRAPHIC img142447830_3.jpg GRAPHIC 81623
6 GRAPHIC img142447830_4.jpg GRAPHIC 61969
  Complete submission text file 0000950170-24-049207.txt   2244993

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20240425.xsd EX-101.SCH 24436
19 EXTRACTED XBRL INSTANCE DOCUMENT stro-20240425_htm.xml XML 113841
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38662 | Film No.: 24884354
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)